Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)

CUSIP: 690469101

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
+3,216,931
Put/Call ratio
64%
SEC-reported price per share
$5.74
Number of holders
90
Value change
+$11,138,040
Number of buys
42
Open additional details 1 more signal available
Number of sells
41
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
187,450,569

Security key

690469101

Report period

Q3 2020

Institutions

90

Top holders

10

Ownership snapshot

Top reported holders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $21,477,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $21.48M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $21.48M
Consonance Capital Management LP $18.95M
BVF INC/IL $17.63M
VANGUARD GROUP INC $15.64M
FMR LLC $13.13M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$21,477,000
2,914,107 shares
— 30 Jun 2020
Consonance Capital Management LP
13F
Company
13F
—
denominator unverified
$18,947,000
2,570,878 shares
— 30 Jun 2020
BVF INC/IL
13F
Company
13F
—
denominator unverified
$17,630,000
2,392,151 shares
— 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$15,636,000
2,121,632 shares
— 30 Jun 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$13,128,000
1,781,215 shares
— 30 Jun 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$5,424,000
735,956 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
25,114,493
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
78
Q3 2020 holders
90
Holder diff
12
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .